BFRI Biofrontera Inc.
Biofrontera Inc. (BFRI) is expected to report earnings on November 12, 2026, before the market open. The consensus earnings estimate is a loss of $0.33 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.4% since its last earnings release on August 13, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics.
Sector
Healthcare
Industry
Biotechnology